Published in Women's Health Weekly, September 23rd, 2004
In the September 2, 2004, New England Journal of Medicine, investigators from several major cancer research groups report that adding radiation to post-surgical tamoxifen treatment of women age 70 or older does not improve survival, has minimal impact on the risk of local tumor recurrence, and does not prevent the need for eventual mastectomy.
"If a patient does not need to have radiation therapy, her quality of life can improve significantly," says Kevin Hughes, MD, of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.